Wellcome Trust and Merck Launch First of its Kind Joint Venture to Develop Affordable Vaccines for Low-Income Countries
Printable version MSD Wellcome Trust Hilleman Laboratories is a first of its kind research and development joint venture with a not-for-profit mission focusing on developing affordable vaccines to prevent diseases that commonly affect low-income countries. For more information, please see the press release below.
| Attachment | Size |
|---|---|
| MSD_Wellcome_Trust_Hilleman_Lab_Announcement.pdf | 26.27 KB |
